FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer

NCT00564733 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Malignant Pleural Effusion
Stage IIIB Non-small Cell Lung Cancer
Stage IV Non-small Cell Lung Cancer

Interventions

DRUG: carboplatin
DRUG: docetaxel
DRUG: gemcitabine hydrochloride
DRUG: paclitaxel
PROCEDURE: computed tomography
PROCEDURE: positron emission tomography
RADIATION: fludeoxyglucose F 18
OTHER: imaging biomarker analysis

Sponsor

University of Washington

Collaborators

[object Object]